AXGN · Axogen Inc
United States · RS rating 42 · As of 2026-10-14
| Price | 35.14 USD |
|---|---|
| 1-day change | -2.9% |
| RS rating (overall / 1M / 3M / 12M) | 42 / 10 / 29 / 96 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 35 / 40 / 18 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | -35.7% |
| Sales growth Q/Q | -0.3% |
| Distance from 52-week high | +32.1% |
| Market cap (USD) | $1.9B |